Fang-Bo Cui
Overview
Explore the profile of Fang-Bo Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui F, Lv X, Yan C, Eng W, Yu S, Zheng Q
Ann Nucl Med
. 2023 Dec;
38(4):247-263.
PMID: 38145430
Introduction: Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic...
2.
Wu F, Zhang J, Li W, Bian B, Hong Y, Song Z, et al.
Oncotarget
. 2017 Oct;
8(40):67189-67202.
PMID: 28978026
MiR-21 is an oncogenic miR frequently elevated in gastric cancer. Overexpression of miR-21 decreases the sensitivity of gastric cancer cells to trastuzumab, which is a humanized monoclonal antibody targeting human...
3.
Zhang F, Gao E, Shu R, Wang H, Zhang Y, Sun P, et al.
Asian Pac J Cancer Prev
. 2015 Oct;
16(15):6765-8.
PMID: 26434908
Aims: To study the effectiveness of human recombinant endostatin injection (Endostar®) combined with cisplatin doublets in treating advanced non-small cell lung cancer (NSCLC), and to evaluate outcome by CT perfusion...
4.
Wu F, Li R, Yang M, Yue G, Wang H, Liu Q, et al.
Cancer Lett
. 2015 Jan;
363(1):7-16.
PMID: 25592042
Aberrant methylation of the transcription factor AP-2 epsilon (TFAP2E) has been attributed to 5-fluorouridine (5-FU) sensitivity. 5-Aza-2'-deoxycytidine (DAC), an epigenetic drug that inhibits DNA methylation, is able to cause reactive...
5.
Cui F, Liu Q, Li R, Shen J, Wu P, Yu L, et al.
Int J Nanomedicine
. 2014 May;
9:2345-58.
PMID: 24872697
Radiotherapy is the main locoregional control modality for many types of unresectable tumors, including gastric cancer. However, many patients fail radiotherapy due to intrinsic radioresistance of cancer cells, which has...
6.
Cui F, Li R, Liu Q, Wu P, Hu W, Yue G, et al.
Cancer Lett
. 2013 Dec;
346(1):53-62.
PMID: 24333735
Docetaxel (DOC) is widely used as radiosensitizer in various tumors, including gastric cancer (GC), but its therapeutic effect remains to be improved. In this study, using docetaxel-loaded nanoparticles (DOC-NPs) based...